What is the treatment for a patient experiencing bronchospasm?

The treatment for a patient experiencing bronchospasm is primarily beta-2 agonists. These medications work by stimulating beta-2 adrenergic receptors in the bronchial smooth muscle, leading to relaxation and dilation of the airways. This action helps to relieve the symptoms of bronchospasm, which may include wheezing, shortness of breath, and chest tightness.

Beta-2 agonists can be either short-acting, used for quick relief during an asthma attack or bronchospasm episode, or long-acting, utilized for ongoing control of symptoms in chronic respiratory conditions. Their rapid onset of action makes them particularly effective in managing acute bronchospasm, making them the first line of treatment for this condition.

Other treatment options like oral corticosteroids, benzodiazepines, and antihistamines do not directly address the underlying issue of bronchospasm. Oral corticosteroids may be used for their anti-inflammatory properties in chronic conditions, benzodiazepines are primarily used for anxiety or sedation, and antihistamines are effective for allergic reactions but do not relieve bronchospasm. Therefore, beta-2 agonists are the most appropriate choice for managing an acute bronchospasm episode.